Method of preparing(3r,5r)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-((4-hydroxymethylphenylamino)carbonyl)-pyrrol-1-yl)-3,5-dihydroxy-heptanoic acid hemi calcium salt, and method of preparing intermediates used therein
KR20200131382A
Novel salts of pelubiprofen, preparation method thereof and pharmaceutical compositions comprising thereof
KR20190044552A
Pharmaceutical composition for the prevention and the treatment of respiratory deseases
KR102001835B1
Method of preparing (3r,5r)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-((4-hydroxymethylphenylamino)carbonyl)-pyrrol-1-yl)-3,5-dihydroxy-heptanoic acid hemi calcium salt, intermediates used therein, and method of preparing the intermediates
Pharmaceutical composition comprising rosuvastatin with improved stability
KR20190023940A
Composite formulation comprising telmisartan, amlodipine and rosuvastatin with improved stability and dissolution rate, and a process for the preparation thereof
KR20190023939A
Composite formulation comprising telmisartan, amlodipine and rosuvastatin and a process for the preparation thereof
KR20180115379A
A pharmaceutical composition comprising angiotensin receptor blocker
KR20170001668A
Pharmaceutical composition comprising the isopropanol extract of artemisia
KR20180024505A
Formulation of fenofibric acid with improved bioavailability
KR20170073780A
A method for preparing artemisia extract with a reduced content of benzopyrene
KR20170012703A
A pharmaceutical composition comprising telmisartan and a preparation method thereof
KR20170001921A
A pharmaceutical composition comprising telmisartan with increased stability and a preparation method thereof
KR20170000907A
Pharmaceutical composition comprising the isopropanol extract of artemisia
KR20160124368A
PHARMACEUTICAL COMPOSITION WITH INCREASED BIOAVAILABILITY COMPRISING PROPIONIC ACID DERIVED NSAIDs AND PPI
KR20160117843A
Crystalline form and Method of preparing the same
KR20160110868A
Pharmaceutical Compositioin with Increased Stability Comprising Mazindol
